MR [Mindray Medical International] 6-K: Mindray Medical to Acquire the Remaining Stake in

Ticker: MR, Company: Mindray Medical International LTD, Type: 6-K, Date: 2015-07-07
Original SEC Filing: Click here


Webplus: MR/20150707/6-K/2_EX-99.1/000.htm SEC Original: v414987_ex99-1.htm
Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio . SHENZHEN, China, July 7, 2015 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. (“Dragonbio”) for approximately US$72.6 million Dragonbio is a domestic




Webplus: MR/20150707/6-K/1/000.htm SEC Original: v414987_6k.htm



Company Information:

Ticker: MR, Company: Mindray Medical International LTD, Type: 6-K, Date: 2015-07-07CIK: 0001373060, Location: F4, SIC: 3841, SIC Desc: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Business Phone & Address:
MINDRAY BUILDING, KEJI 12TH ROAD SOUTH
SHENZHEN 518057

Home Page Forums

By | 2016-03-28T23:47:58+00:00 July 7th, 2015|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar